| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2309 | 2004 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1565 | 2011 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial Parkinson Study Group, Parkinson Study Group Jama 284 (15), 1931-1938, 2000 | 1090 | 2000 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 892 | 2017 |
| Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease AW Dunah, H Jeong, A Griffin, YM Kim, DG Standaert, SM Hersch, ... Science 296 (5576), 2238-2243, 2002 | 857 | 2002 |
| Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors S Patel, K Lorincz, R Hughes, N Huggins, J Growdon, D Standaert, ... IEEE transactions on information technology in biomedicine 13 (6), 864-873, 2009 | 739 | 2009 |
| Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ... The Lancet Neurology 13 (2), 141-149, 2014 | 731 | 2014 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ... Archives of neurology 61 (7), 1044-1053, 2004 | 686 | 2004 |
| A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice JF Chen, Z Huang, J Ma, JM Zhu, R Moratalla, D Standaert, ... Journal of Neuroscience 19 (21), 9192-9200, 1999 | 662 | 1999 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 631 | 2011 |
| Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat CM Testa, DG Standaert, AB Young, JB Penney Journal of Neuroscience 14 (5), 3005-3018, 1994 | 598 | 1994 |
| Molecular markers of early Parkinson's disease based on gene expression in blood CR Scherzer, AC Eklund, LJ Morse, Z Liao, JJ Locascio, D Fefer, ... Proceedings of the National Academy of Sciences 104 (3), 955-960, 2007 | 592 | 2007 |
| Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels JR Meyers, RB MacDonald, A Duggan, D Lenzi, DG Standaert, JT Corwin, ... Journal of Neuroscience 23 (10), 4054-4065, 2003 | 558 | 2003 |
| A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study Parkinson Study Group Archives of Neurology 62 (2), 241-248, 2005 | 545 | 2005 |
| Atriopeptins as cardiac hormones. P Needleman, SP Adams, BR Cole, MG Currie, DM Geller, ML Michener, ... Hypertension 7 (4), 469-482, 1985 | 536 | 1985 |
| The pharmacological basis of therapeutics LL Brunton, B Chabner, BC Knollmann McGraw-Hill, 2011 | 535* | 2011 |
| The pathophysiological basis of dystonias XO Breakefield, AJ Blood, Y Li, M Hallett, PI Hanson, DG Standaert Nature Reviews Neuroscience 9 (3), 222-234, 2008 | 521 | 2008 |
| LRRK2 inhibition attenuates microglial inflammatory responses MS Moehle, PJ Webber, T Tse, N Sukar, DG Standaert, TM DeSilva, ... Journal of Neuroscience 32 (5), 1602-1611, 2012 | 494 | 2012 |
| Spinal and trigeminal dorsal horn projections to the parabrachial nucleus in the rat DF Cechetto, DG Standaert, CB Saper Journal of Comparative Neurology 240 (2), 153-160, 1985 | 461 | 1985 |
| Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat DG Standaert, CM Testa, AB Young, JB Penney Jr Journal of Comparative Neurology 343 (1), 1-16, 1994 | 448 | 1994 |
Ashley S. HarmsUniversity of Alabama at BirminghamEmail verificata su uab.edu
